Patient Activation and Diabetes Outcomes Among Jordanian Patients With Type 2 Diabetes: Longitudinal Evidence on Adherence and Glycemic Control With Linear Mixed Model Analysis.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Patient Activation and Diabetes Outcomes Among Jordanian Patients With Type 2 Diabetes: Longitudinal Evidence on Adherence and Glycemic Control With Linear Mixed Model Analysis.
Συγγραφείς: Alosta MR; Faculty of Nursing, Zarqa University, Zarqa, Jordan., Atiyeh H; Faculty of Nursing, Philadelphia University, Amman, Jordan., Hani SB; Faculty of Nursing, Irbid National University, Irbid, Jordan., Hamdan-Mansour A; School of Nursing, The University of Jordan, Amman, Jordan., Al-Yyan AA; Faculty of Nursing, Zarqa University, Zarqa, Jordan., Afaneh T; Faculty of Nursing, Zarqa University, Zarqa, Jordan., Sarhan R; Prince Hamza Hospital, Amman, Jordan., Al-Momani M; Faculty of Nursing, Zarqa University, Zarqa, Jordan., Othman EH; Clinical Nursing Department, Faculty of Nursing, Applied Science Private University, Amman, Jordan.
Πηγή: Research in nursing & health [Res Nurs Health] 2026 Oct; Vol. 49 (5), pp. 564-573. Date of Electronic Publication: 2026 May 13.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wiley Country of Publication: United States NLM ID: 7806136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-240X (Electronic) Linking ISSN: 01606891 NLM ISO Abbreviation: Res Nurs Health Subsets: MEDLINE
Imprint Name(s): Original Publication: New York, Wiley.
Ιατρικοί όροι (MeSH): Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/psychology , Diabetes Mellitus, Type 2*/therapy , Glycemic Control*/statistics & numerical data , Glycemic Control*/psychology , Medication Adherence*/psychology , Patient Participation*/statistics & numerical data , Patient Participation*/psychology , Drug Monitoring*, Glycated Hemoglobin/analysis ; Hypoglycemic Agents/therapeutic use ; Humans ; Jordan ; Female ; Male ; Middle Aged ; Longitudinal Studies ; Adult ; Aged ; Blood Glucose ; Adherence Interventions
Περίληψη: Management of chronic diseases like diabetes mellitus (DM) requires patient activation. Although many studies have associated patient activation with outcomes like increased medication adherence and better blood glucose control, evidence for these outcomes is scarce in the Middle East, particularly in the Jordanian population. To address this issue, the current study examined the association between patient activation and both medication adherence and glycemic control among patients with diabetes in Jordan. A descriptive longitudinal method was used, and convenience sampling was adopted. Newly diagnosed adult patients with diabetes were assessed utilizing the Patient Activation Measure (PAM-13), Adherence to Refills and Medications Scale (ARMS), and glycemic control was evaluated by HbA1c levels. Data were collected from 140 patients at baseline, 3 months, and 6 months from hospital inpatient departments and outpatient clinics. PAM scores increased from 44.7 at baseline to 54.5 at 3 months and 60.0 at 6 months. ARMS scores dropped from 34.4 to 29.7 and 25.3, indicating progressive improvement in medication adherence, and HbA1c from 10.6% to 9.6% and 8.7%. Better activation was significantly associated with higher adherence (F(1, 335.1) = 315.43, p < 0.001) and lower HbA1c (F(1, 362.2) = 414.38, p < 0.001). Time and activation interplay were prominent for adherence (F(2, 177.1) = 3.15, p = 0.045) and HbA1c (F(2, 165.2) = 6.04, p = 0.002). These findings suggest that patient activation is associated with improved health outcomes at 6 months. This finding thus supports prioritizing structured education and support in diabetes care to enhance and maintain patient activation.
(© 2026 Wiley Periodicals LLC.)
References: Aust J Prim Health. 2020 Dec;26(6):431-442. (PMID: 33222755)
Aust J Prim Health. 2019 Jan;25(6):526-533. (PMID: 31710832)
Am J Health Promot. 2024 Jul;38(6):767-777. (PMID: 38146875)
Patient Educ Couns. 2017 Jul;100(7):1268-1275. (PMID: 28159442)
Health Qual Life Outcomes. 2024 May 20;22(1):39. (PMID: 38764032)
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30. (PMID: 16336556)
BMC Psychiatry. 2025 May 22;25(1):520. (PMID: 40405139)
Diabetes Educ. 2019 Apr;45(2):174-183. (PMID: 30658558)
J Health Popul Nutr. 2023 Nov 7;42(1):122. (PMID: 37936205)
Patient Prefer Adherence. 2016 Jun 10;10:1051-62. (PMID: 27354775)
J Patient Exp. 2021 Aug 10;8:23743735211036524. (PMID: 34395852)
Value Health. 2009 Jan-Feb;12(1):118-23. (PMID: 19911444)
Public Health Nurs. 2020 Mar;37(2):178-187. (PMID: 31833102)
J Diabetes Res. 2023 Nov 27;2023:2074560. (PMID: 38059208)
Healthcare (Basel). 2023 Dec 04;11(23):. (PMID: 38063658)
Prim Care Diabetes. 2020 Feb;14(1):12-20. (PMID: 31543458)
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. (PMID: 15230939)
BMJ Open. 2025 May 27;15(5):e095456. (PMID: 40436451)
BMJ Open. 2020 May 17;10(5):e034757. (PMID: 32423931)
Curr Diabetes Rev. 2023;19(5):e311022210519. (PMID: 36321235)
BMC Health Serv Res. 2016 Oct 12;16(1):570. (PMID: 27729079)
Diabetes Spectr. 2010 Jul 1;23(3):171-176. (PMID: 26005310)
J Diabetes Metab Disord. 2022 Jan 29;21(1):219-228. (PMID: 35673517)
Patient Prefer Adherence. 2022 Feb 19;16:449-465. (PMID: 35221675)
Sci Diabetes Self Manag Care. 2024 Dec;50(6):532-545. (PMID: 39320149)
Biopsychosoc Med. 2021 Jan 18;15(1):1. (PMID: 33461565)
Patient Prefer Adherence. 2018 Dec 28;13:73-81. (PMID: 30643392)
BMC Nephrol. 2024 Jul 20;25(1):232. (PMID: 39033115)
BMJ Open Diabetes Res Care. 2020 Dec;8(2):. (PMID: 33323460)
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. (PMID: 38078586)
Curr Diab Rep. 2024 Feb;24(2):19-25. (PMID: 38112977)
Innovation (Camb). 2023 May 26;4(4):100450. (PMID: 37485083)
Contributed Indexing: Keywords: diabetes management; glycemic control; medication adherence; patient activation; patients with diabetes
Substance Nomenclature: 0 (Glycated Hemoglobin)
0 (Blood Glucose)
0 (Hypoglycemic Agents)
Entry Date(s): Date Created: 20260513 Date Completed: 20260903 Latest Revision: 20260905
Update Code: 20260905
PubMed Central ID: PMC13539640
DOI: 10.1002/nur.70080
PMID: 42126029
Βάση Δεδομένων: MEDLINE